MedPath

Supporting Methods in Cardiovascular Diseases Rehabilitation

Not Applicable
Completed
Conditions
Depressive Symptoms
Coronary Artery Disease
Cardiovascular Diseases
Anxiety
Mood Disorders
Stress
Interventions
Behavioral: Cardiac rehabilitation
Behavioral: Relaxation-therapeutic recordings
Device: Virtual reality therapy
Behavioral: Schultz Autogenic Training
Registration Number
NCT06241534
Lead Sponsor
Wroclaw University of Health and Sport Sciences
Brief Summary

The study evaluates how various therapeutic approaches perform in addressing depression, anxiety symptoms, and stress levels among patients in the second stage of cardiac rehabilitation. This study aims to evaluate the influence of the used therapeutic approaches on psychological outcomes and to compare the effectiveness of these therapies.

Detailed Description

Depression, anxiety, and high levels of perceived stress are increasingly common problems associated with cardiovascular disease (CVD). The relationship between anxiety-depressive disorders and the risk of CVD is confirmed by behavioral and physiological mechanisms. According to the American Heart Association, depression is a negative prognostic factor at all stages of treatment of CVD. The most important risks in people with CVD and anxiety-depressive disorders, as comorbidities, are an increased risk of recurrent cardiovascular events and increased mortality. However, psychological disorders in patients with CVD are still not sufficiently diagnosed and, consequently, are not adequately treated. Therefore, it is necessary to look for effective methods to support cardiac rehabilitation from a psychological perspective.

The first group of patients will receive relaxation-therapeutic recordings (referred to as the Recording Group) in addition to monitored cardiac physical training. The second group will receive virtual reality (VR) therapy (referred to as the VR Group) alongside monitored cardiac physical training. The third group (referred to as the Control Group) will receive Schultz Autogenic Training as a standard supplement to cardiological training.

The aims of the study:

1. The evaluation of the influence of relaxation-therapeutic recordings on the anxiety-depressive symptoms and the stress level of the patients undergoing second stage of cardiac rehabilitation.

2. The comparison of the effectiveness of therapeutic recordings with the effectiveness of VR therapy and Schultz Autogenic Training.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
45
Inclusion Criteria
  • Coronary Artery Disease;
  • the second stage of cardiac rehabilitation conducted in outpatient settings
Exclusion Criteria
  • inability to self-complete the research questionnaires;
  • presence of the following issues at the time of the examination or in the medical data: disturbances of consciousness, psychotic symptoms or other serious psychiatric disorders;
  • initiation of psychiatric treatment during the research project;
  • contraindications for virtual therapy (epilepsy, vertigo, eyesight impairment);
  • the patient's refusal at any stage of the research project.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Recordings GroupCardiac rehabilitationCardiac rehabilitation supplemented by relaxation-therapeutic recordings
VR GroupCardiac rehabilitationCardiac rehabilitation supplemented by VR therapy
Recordings GroupRelaxation-therapeutic recordingsCardiac rehabilitation supplemented by relaxation-therapeutic recordings
VR GroupVirtual reality therapyCardiac rehabilitation supplemented by VR therapy
Control GroupCardiac rehabilitationCardiac rehabilitation supplemented by Schultz Autogenic Training
Control GroupSchultz Autogenic TrainingCardiac rehabilitation supplemented by Schultz Autogenic Training
Primary Outcome Measures
NameTimeMethod
Hospital Anxiety and Depression Scale Hospital Anxiety and Depression Scale15 minutes

The Hospital Anxiety and Depression Scale (HADS) is a fourteen-item scale scoring from 0 to 3 for each item. The first seven items relate to anxiety (HADS-A), and the remaining seven items relate to depression (HADS-D). The global scoring ranges from 0 to 42 with a cut-off point of 8/21 for anxiety and 8/21 for depression. The higher the score, the greater anxiety or depression symptoms. HADS will be performed at the beginning and after four weeks of treatment.

Perception of Stress Questionnaire20 minutes

The Perception of Stress Questionnaire (PSQ) was created by Plopa and Makarowski. It is a 27-item scale scoring from 1 to 5 points for each item, where 21 items examine the level of stress in the areas of emotional tension, external stress and intrapsychic stress, and six items refer to the lie scale. The global scoring for the perception of stress ranges from 21 to 105, with a cut-off point of 60 for an elevated level of perceived stress. Higher scores indicate higher stress perception.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Cardiology Center Pro Corde

🇵🇱

Wrocław, Poland

© Copyright 2025. All Rights Reserved by MedPath